Predict your next investment

ReGelTec company logo
HEALTHCARE | Medical Devices & Equipment
regeltec.com

See what CB Insights has to offer

Founded Year

2018

Stage

Series A | Alive

Total Raised

$5.75M

Last Raised

$3.75M | 1 yr ago

About ReGelTec

​ReGelTec is a medical device company that is developing minimally invasive spinal implants for lower back pain and degenerative disc disease.

ReGelTec Headquarter Location

323 W. Camden Street Suite 600

Baltimore, Maryland, 21201,

United States

443-451-3915

Latest ReGelTec News

ReGelTec Inc receives FDA breakthrough device designation for hydrogel injection

Dec 13, 2020

Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio ReGelTec Inc. announced it has received breakthrough device designation from the FDA for its Hydrafil system for the treatment of degenerative disc disease and chronic low back pain. A hydrogel that is heated prior to injection into the nucleus of a degenerated disc, the Hydrafil system forms a contiguous implant to augment the disc, restore the biomechanical properties of the spinal segment and alleviate pain, according to a company press release. The release noted ReGelTec Inc. has completed procedures in 20 patients as part of an ongoing early feasibility study in Barranquilla, Colombia, with indications of significant pain relief and reduction of disability at 30- and 90-day follow-up visits. The company also announced  it has raised $4 million for its Series A financing to support the ongoing clinical and development work of this system. Douglas Beall “I am happy that the FDA has recognized the potential of Hydrafil to treat one of the most prevalent, debilitating and costly conditions that I see in my practice in patients with chronic low back pain and degenerative disc disease,” Douglas Beall, MD, chair of the medical advisory board for ReGelTec Inc., said in the release. “This designation will allow us to more rapidly move clinical work to the U.S. and expand our clinical trials, building on the promising results of the early feasibility study.”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ReGelTec

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ReGelTec is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

8,001 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

ReGelTec Patents

ReGelTec has filed 2 patents.

The 3 most popular patent topics include:

  • Bones of the vertebral column
  • Dosage forms
  • Drug delivery devices
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/23/2020

3/23/2021

Bones of the vertebral column, Dosage forms, Drug delivery devices, Neurosurgery, Ligaments of the torso

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/23/2020

00/00/0000

Grant Date

3/23/2021

00/00/0000

Title

Subscribe to see more

Related Topics

Bones of the vertebral column, Dosage forms, Drug delivery devices, Neurosurgery, Ligaments of the torso

Subscribe to see more

Status

Grant

Subscribe to see more

ReGelTec Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ReGelTec Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.